Human Technologies (TSE:5621) ROE %: 19.28% (As of Mar. 2026) — 22% Above Median


TSE:5621 Human Technologies Inc TSE:5621
23 GF Score
Price 円1,436.00
! 1 Warning Sign
View Full Analysis

What is Human Technologies ROE %?

Human Technologies TSE:5621 +1.92% 23 ROE % is 19.28% as of Mar. 2026, which is 22% above its 10-year median of 15.75. GuruFocus rates TSE:5621 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 2,677 Software companies, Human Technologies ranks better than 83.23% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Human Technologies's annualized net income for the quarter that ended in Mar. 2026 was 円969 Mil. Human Technologies's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was 円5,023 Mil. Therefore, Human Technologies's annualized ROE % for the quarter that ended in Mar. 2026 was 19.28%.

The historical rank and industry rank for Human Technologies's ROE % or its related term are showing as below:

TSE:5621' s ROE % Range Over the Past 10 Years
Min: 11.51   Med: 15.75   Max: 24.16
Current: 21.06

During the past 5 years, Human Technologies's highest ROE % was 24.16%. The lowest was 11.51%. And the median was 15.75%.

TSE:5621's ROE % is ranked better than
83.23% of 2677 companies
in the Software industry
Industry Median: 4.69 vs TSE:5621: 21.06

Human Technologies  (TSE:5621) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=968.646/5022.9945
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(968.646 / 7766.586)*(7766.586 / 6446.559)*(6446.559 / 5022.9945)
=Net Margin %*Asset Turnover*Equity Multiplier
=12.47 %*1.2048*1.2834
=ROA %*Equity Multiplier
=15.02 %*1.2834
=19.28 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=968.646/5022.9945
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (968.646 / 1304.534) * (1304.534 / 1288.04) * (1288.04 / 7766.586) * (7766.586 / 6446.559) * (6446.559 / 5022.9945)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7425 * 1.0128 * 16.58 % * 1.2048 * 1.2834
=19.28 %

Note: The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Human Technologies ROE % Related Terms


Human Technologies ROE % Historical Data

* Premium members only.

The historical data trend for Human Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Technologies ROE % Chart

Human Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROE %
24.16 12.67 11.51 15.75 20.95

Human Technologies Semi-Annual Data
Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Get a 7-Day Free Trial 13.77 21.96 9.71 23.11 19.28

TSE:5621 vs MSFT, ORCL, PLTR: ROE % Comparison

For the Software - Infrastructure subindustry, Human Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Technologies ROE % vs Software Industry

For the Software industry and Technology sector, Human Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where Human Technologies's ROE % falls into.


TSE:5621
23GF Score
Human Technologies Inc TSE:5621
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Technologies ROE % Calculation

Human Technologies's annualized ROE % for the fiscal year that ended in Mar. 2026 is calculated as

ROE %=Net Income (A: Mar. 2026 )/( (Total Stockholders Equity (A: Mar. 2025 )+Total Stockholders Equity (A: Mar. 2026 ))/ count )
=1016.322/( (4431.379+5270.895)/ 2 )
=1016.322/4851.137
=20.95 %

Human Technologies's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=968.646/( (4775.094+5270.895)/ 2 )
=968.646/5022.9945
=19.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 19.28% mean?
Human Technologies (TSE:5621) has a ROE % of 19.28% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Human Technologies and its competitors. This is 22% above median its historical median of 15.75. Over the past decade, Human Technologies' ROE % has ranged from 11.51 to 24.16. According to the industry distribution chart, Human Technologies ranks #449 out of 2677 companies in the Software industry, placing it in the top 16.8%.
Is Human Technologies' ROE % too high?
Human Technologies' current ROE % of 19.28% is 22% above median its 10-year median of 15.75. Over the past 10 years, this metric has ranged from a low of 11.51 to a high of 24.16. The Software industry median ROE % is 4.69. Human Technologies' value of 19.28% is 311.1% above this industry median. Based on the distribution chart, Human Technologies ranks #449 out of 2677 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Human Technologies has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Human Technologies' ROE % compare to MSFT and ORCL?
According to the Software industry distribution chart, Human Technologies ranks #449 out of 2677 companies for ROE %. This places Human Technologies in the top 17% of its industry — outperforming the majority of peers. The industry median ROE % is 4.69. Human Technologies' value of 19.28% is 311.1% above this benchmark. Historically, Human Technologies' own ROE % has ranged from 11.51 to 24.16 over the past decade. While the company's 10-year median is 15.75 vs. the industry median of 4.69, Human Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Software company?
The median ROE % among Software companies is 4.69, based on 2,677 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Technologies's current ROE % of 19.28% is 311.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Human Technologies and its competitors. For the Software industry, the median ROE % is 4.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Technologies's current ROE % is 19.28%, which is 22% above median its own 10-year median of 15.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Technologies stock overvalued right now?
Human Technologies (TSE:5621) has a current ROE % of 19.28%. The current ROE % is 19.28%, which is 22% above median its 10-year median of 15.75 and 311.1% above the Software industry median of 4.69. Human Technologies' overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Human Technologies (TSE:5621), the current ROE % is 19.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Human Technologies Business Description

Address 1-6-6 Motoakasaka, Minato-ku, Tokyo, JPN, 107-0051
Human Technologies Inc is a company engaged in the development and provision of cloud services centered on attendance management. It provides product services that combine business systems based on cloud computing and biometric authentication technology. The Group operates in a single segment, the attendance management SaaS business.
23GF Score

Get the complete analysis for TSE:5621

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,436.00
Price